Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LMNB1 divergent transcript (LMNB1-DT) is a long noncoding RNA gene transcribed from the region adjacent to the LMNB1 coding gene, typically in the antisense or divergent orientation[3]. Its function is not fully understood, but by analogy to other divergent lncRNAs at protein-coding loci, LMNB1-DT may play a regulatory role in modulating LMNB1 expression, affecting nuclear architecture, chromatin organization, or transcriptional regulation[1][3]. As of now, it is not a recognized therapeutic target and does not have established roles in disease, direct drug interactions, or biomarker utility[3]. The gene is catalogued in gene databases such as GeneCards as an RNA gene with conserved expression patterns[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on LMNB1 divergent transcript (LMNB1-DT).